Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) Stock Price

QNRXStock
$6.1217.07%52W
Market Cap$12.29M
P/E
PEG Ratio
Div yield
Beta1.58

QNRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-41.91%
Price vs S&P 500 (4W)35.99%
VGM Score61.03

QNRX Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$1.77-$1.90-7.15%(-$0.13)
Q1 2026-$2.26-$1.77+21.68%(+$0.49)
Q4 2025-$4.02-$1.74+56.72%(+$2.28)
Q3 2025-$1.92-$6.70-248.78%(-$4.78)
Q2 2025-$4.55-$6.27-37.88%(-$1.72)

QNRX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.13
4.11
4.10
4.10

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares
B$6.12
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Quoin Pharmaceuticals, Ltd. American Depositary Shares

Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing treatments for rare and orphan diseases. The company's pipeline of three products targets multiple indications including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, and Epidermolysis Bullosa.